Skip to main content

Table 4 Characteristics of patients in eligible studies

From: Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials

 

Age

Male sex (%)

Hypertension (%)

Diabetes mellitus (%)

Smoker (%)

Previous MI (%)

ACS (%)

Stable angina (%)

BIO-RESORT

64 ± 11

72

46

18

30

19

70

30

BIOFLOW II

63 ± 10

77

78

28

27

27

NR

NR

BIOFLOW V

65 ± 10

74

80

35

23

27

51

48

BIOSCIENCE

66 ± 12

77

68

23

29

20

53

31

ORIENT

65 ± 11

72

65

26

27

NR

45

55

PRISON IV

63 ± 10

78

56

20

33

30

17

70